Navigation Links
Interventional Spine®, Inc. Announces Issuance of Key Patents for the PERPOS® PLS System
Date:11/4/2010

IRVINE, Calif., Nov. 4, 2010 /PRNewswire/ -- Interventional Spine®, Inc. today announced that the United States Patent Office has issued U.S. Patent No. 7,824,429, entitled Method and Apparatus for Spinal Fixation.  This patent includes 43 claims that provide key patent protection for the Company's percutaneous transfacet-pedicular compression system for posterior spine fixation sold under the PERPOS® PLS System name and including the Company's BONE-LOK® implant.  This patent further strengthens the Company's patent portfolio for its key technologies, which also includes the patented CLASP® (Compression Locking Anchor with Secondary Purchase) Technology.

(Logo:  http://photos.prnewswire.com/prnh/20100419/LA88318LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100419/LA88318LOGO)

Interventional Spine®, Inc. is a leading innovator of percutaneous technologies in the treatment of back pain with over 10,000 patients being treated to date with the PERPOS® PLS System and the BONE-LOK® implant.

The PERPOS® PLS System is a complete set of instruments engineered for percutaneous implantation of the BONE-LOK® implant, which is a unique one-size fits all implant that enables single or multi-level bilateral fixation without rods and screws.  The BONE-LOK® implant with CLASP® Technology provides higher compression capabilities than standard devices which can lead to better stability during a fusion procedure of the lower spine.  It also provides intraoperative flexibility for surgeons.

Interventional Spine®, Inc. is a privately held company based in Irvine, California, that designs, develops and markets patented implantable devices for the spine that can be deployed via percutaneous techniques. Supported by the Company's unique product introduction systems, Interventional Spine's products provide benefits to patients, surgeons and hospitals alike.  More information on the Company and its products can be found at: www.i-spineinc.com.FOR FURTHER INFORMATION CONTACT:  Walter A. CuevasChief Executive Officer949-472-0006
'/>"/>

SOURCE Interventional Spine, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Drug-Coated Balloons Slowly Making Their Mark on the European Interventional Cardiology Market
2. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
3. MultiCells Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
4. Interventional Spine®, Inc. Awarded the 2010 Best New Technology in Cervical Care Award
5. Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C.
6. CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010
7. Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
8. American Society of Interventional Pain Physicians (ASIPP) Promotes Patient Education and Outreach Initiatives During National Pain Awareness Month
9. Society of Interventional Radiology Supports Research for New M.S. Treatments
10. Interventional Spine®, Inc. Announces Continued Success With Its Unique PERPOS® Percutaneous Cervical System
11. Concert Medical Launches Conductor™ Family of Interventional Coronary Guidewires
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):